Howard Chew, lymphoma survivor, underwent a clinical trial of CAR T-cell therapy. At first, it didn’t work, but a second treatment proved successful. Chew tells his story and Elizabeth Budde, M.D., P.H.D., City of Hope hematologist-oncologist, talks about the development of the therapy and its benefits.